FDA green lights first-ever RSV vaccine for adults 60+

Source:

The following is an excerpt from Medpage Today. The FDA has approved the first-ever vaccine for respiratory syncytial virus (RSV) the agency announced on Wednesday. Marketed under the trade name of Arexvy, the adjuvanted RSV prefusion F protein-based vaccine is specifically indicated for preventing lower respiratory tract infections in adults 60 and over. Until now, no […]

Continue reading FDA green lights first-ever RSV vaccine for adults 60+ on sharylattkisson.com.

0 0 votes
Article Rating

Follow Sharyl Attkisson on:

VIEW MORE FROM Sharyl Attkisson

Support Sharyl Attkisson

Order the New York Times bestseller “The Smear” today online or borrow from your library

FULL MEASURE NEWS

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments